These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24077549)

  • 1. [Attention deficit syndrome in adults: clinical, psychophysiological features and treatment].
    Chutko LS; Surushkina SIu; Iakovenko EA; Nikishena IS; Anisimova TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(8):38-41. PubMed ID: 24077549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adaptol in the treatment of ADHD].
    Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Anisimova TI; Sergeev AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(8):45-8. PubMed ID: 19738569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attention deficit hyperactivity disorder with comorbid anxiety disorders: pharmacotherapy options].
    Zavadenko NN; Solomasova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):44-8. PubMed ID: 23096041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A dyad approach to the treatment of attention deficit hyperactivity disorder].
    Chutko LS; Surushkina SY; Anisimova TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):81-84. PubMed ID: 28374698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurocirculatory asthenia: psychoautonomic features and treatment possibilities].
    Frolova NL; Chutko LS; Surushkina SIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):51-4. PubMed ID: 23388593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impulsivity in adolescents with attention deficit hyperactivity disorder].
    Chutko LS; Surushkina EY; Yakovenko EA; Kropotov YD; Anisimova TI; Sergeev AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):13-17. PubMed ID: 28300808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic significance of brain-derived neurotrophic factor (BDNF) for phobic anxiety disorders, vegetative and cognitive impairments during conservative treatment including adaptol of some functional and organic diseases of nervous system].
    Zhivolupov SA; Samartsev IN; Marchenko AA; Puliatkina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):37-41. PubMed ID: 22810739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Generalized anxiety disorder: psychosomatic aspects and treatment approaches].
    Chutko LS; Rozhkova AV; Sidorenko VA; Surushkina SIu; Tursunova KB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(1):40-4. PubMed ID: 22678674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical-neurophysiological study of efficacy of adaptol in discirculatory encephalopathy].
    Barantsevich ER; Posokhina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9 Pt 2):68-72. PubMed ID: 22027612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder.
    Manor I; Newcorn JH; Faraone SV; Adler LA
    Postgrad Med; 2013 Jul; 125(4):181-90. PubMed ID: 23933905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and neurophysiological study of the efficacy of adaptol in the treatment of emotional burn-out].
    Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Rozhkova AV; Anisimova TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):30-3. PubMed ID: 21183911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An open comparative observational study of the efficacy and safety of adaptol in anxiety-asthenic disorders in patients with chronic cerebral ischemia].
    Vorob'eva OV; Repina VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(3):20-24. PubMed ID: 27070467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label, dose-titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention-deficit/hyperactivity disorder.
    Takahashi M; Goto T; Takita Y; Chung SK; Wang Y; Gau SS
    Asia Pac Psychiatry; 2014 Mar; 6(1):62-70. PubMed ID: 23857916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
    Wilens TE; Biederman J; Prince J; Spencer TJ; Faraone SV; Warburton R; Schleifer D; Harding M; Linehan C; Geller D
    Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychoautonomic disorders in patients with hypertension, stage I and possibilities of their treatment].
    Frolova NI; Chutko LS; Surushkina SY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):43-7. PubMed ID: 24107879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioning.
    Wietecha L; Young J; Ruff D; Dunn D; Findling RL; Saylor K
    Clin Neuropharmacol; 2012; 35(3):125-33. PubMed ID: 22561876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder.
    Davids E; Kis B; Specka M; Gastpar M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1033-8. PubMed ID: 16698160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.